companydata.dkcompanydata.dk

neu biologica ApS: Financial statements 2023

CVR: 42378666

Source: annual report 2023, Danish Business Authority

01/07/2022 – 30/06/2023

neu biologica ApS (CVR 42378666) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 108,945 and a net result of DKK 84,991. Equity in the 2023 report amounted to DKK 98,173. The solvency ratio was 60.7%.

Gross Profit
DKK 108,945
Profit/Loss
DKK 84,991
Equity
DKK 98,173
Total Assets
DKK 161,685
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About neu biologica ApS

neu biologica ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2021. The company has been dissolved on 12 December 2024. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 108,945 and a net result of DKK 84,991. Equity in the 2023 report amounted to DKK 98,173.

Source: annual report 2023, Danish Business Authority